New river blindness drug approved

The United States Food and Drug Administration (FDA) has approved moxidectin as the first new treatment for river blindness in 20 years, adding new ammunition...

US$5M gift to support vision research

Wills Eye Hospital in Philadelphia has been given US$5 million to establish a new vision research centre, named after philanthropists Vickie and Jack Farber,...

Deformation may predict glaucoma prognosis

A recent Seoul University study has found a link between how much the lamina cribrosa - a thin, sieve-like portion of sclera at the base of the optic disc...

Essilor Luxottica delay

Essilor and Luxottica have announced an extension to the July 31 of the deadline for finalising the merger of the two companies, but remain optimistic...

Vista sells Bollé

Vista Outdoor is selling its international eyewear brands, Bollé, Cébé and Serengeti, to a European private equity fund, for an estimated US$158 million,...

New direction for BHVI

Australia’s Brien Holden Vision Institute has announced a change in leadership and a shift in focus to address future needs for both the ophthalmic industry...

Australia funds diabetes screening

The Australian government’s decision to develop a national diabetes eye screening programme is a major step in the fight against diabetes-related vision...

ODMA fair now O=MEGA

The Optical Distributors & Manufacturers Association of Australia (ODMA) and the Victorian arm of Optometry Australia, Optometry Victoria, have joined...

Bottom Banner Advert